{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:10:17Z","timestamp":1788307817825,"version":"build-2803163510"},"reference-count":46,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2,1]]},"abstract":"<jats:p>Yellow fever vaccine provides long-lasting immunity. Rare serious adverse events after vaccination include neurologic or viscerotropic syndromes or anaphylaxis. We conducted a systematic review of adverse events associated with yellow fever vaccination in vulnerable populations. Nine electronic bibliographic databases and reference lists of included articles were searched. Electronic databases identified 2,415 abstracts for review, and 32 abstracts were included in this review. We identified nine studies of adverse events in infants and children, eight studies of adverse events in pregnant women, nine studies of adverse events in human immunodeficiency virus-positive patients, five studies of adverse events in persons 60 years and older, and one study of adverse events in individuals taking immunosuppressive medications. Two case studies of maternal\u2013neonate transmission resulted in serious adverse events, and the five passive surveillance databases identified very small numbers of cases of yellow fever vaccine-associated viscerotropic disease, yellow fever vaccine-associated neurotropic disease, and anaphylaxis in persons \u2265 60 years. No other serious adverse events were identified in the other studies of vulnerable groups.<\/jats:p>","DOI":"10.4269\/ajtmh.2012.11-0525","type":"journal-article","created":{"date-parts":[[2012,2,6]],"date-time":"2012-02-06T21:50:37Z","timestamp":1328565037000},"page":"359-372","source":"Crossref","is-referenced-by-count":80,"title":["The Safety of Yellow Fever Vaccine 17D or 17DD in Children, Pregnant Women, HIV+ Individuals, and Older Persons: Systematic Review"],"prefix":"10.4269","volume":"86","author":[{"given":"Roger E.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane L.","family":"Lorenzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Spragins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"R1","series-title":"MMWR Morb Mortal Wkly Rep Recommendations","first-page":"1","article-title":"Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","year":"2010"},{"key":"R2","series-title":"Vaccines","first-page":"959","article-title":"Yellow fever vaccine","year":"2008"},{"key":"R3","series-title":"District Guidelines for Yellow Fever Surveillance","year":"1998"},{"key":"R4","series-title":"Global Health Situation and Projections\u2014Estimates","year":"1992"},{"key":"R5","series-title":"Adv Parasitol","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0065-308X(05)62006-4","article-title":"The global distribution of yellow fever and dengue","volume":"62","year":"2006"},{"key":"R6","series-title":"Vaccine","first-page":"2758","article-title":"17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on Medicine and Health in the Tropics, Marseille, France, Monday 12 September 2005","volume":"25","year":"2007"},{"key":"R7","series-title":"J Virol","first-page":"1032","article-title":"High fidelity of yellow fever virus RNA polymerase","volume":"78","year":"2004"},{"key":"R8","series-title":"International Travel and Health","year":"2011"},{"key":"R9","series-title":"Vaccine","first-page":"5771","article-title":"Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis and presentation of immunization safety data","volume":"25","year":"2007"},{"key":"R10","series-title":"Vaccine","first-page":"5675","article-title":"Anaphylaxis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","year":"2007"},{"key":"R11","series-title":"J Infect Dis","first-page":"1577","article-title":"Immune response during adverse events after 17D-derived yellow fever vaccination in Europe","volume":"197","year":"2008"},{"key":"R12","series-title":"Vaccine","first-page":"3256","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","year":"2005"},{"key":"R13","series-title":"Fundamentals of Biostatistics","first-page":"94","year":"1990"},{"key":"R14","series-title":"Vaccine","first-page":"6077","article-title":"Adverse event reports following yellow fever vaccination","volume":"26","year":"2008"},{"key":"R15","series-title":"Commun Dis Intell","first-page":"244","article-title":"Age-related risk of adverse events following yellow fever vaccination in Australia","volume":"28","year":"2004"},{"key":"R16","series-title":"Emerg Infect Dis","first-page":"945","article-title":"Advanced age a risk factor for illness temporally associated with yellow fever vaccination","volume":"7","year":"2001"},{"key":"R17","series-title":"Hum Vaccin","first-page":"207","article-title":"Yellow fever 17D vaccine safety and immunogenicity in the elderly","volume":"1","year":"2005"},{"key":"R18","series-title":"Am J Trop Med","first-page":"189","article-title":"Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru","volume":"72","year":"2005"},{"key":"R19","series-title":"J Biol Stand","first-page":"9","article-title":"Study of combined vaccination against yellow fever and measles in infants from six to nine months","volume":"17","year":"1989"},{"key":"R20","series-title":"Bull World Health Organ","first-page":"1056","article-title":"Antibody response to 17D yellow fever vaccine in Ghanaian infants","volume":"79","year":"2001"},{"key":"R21","series-title":"Bull Soc Pathol Exot","first-page":"885","article-title":"Saliou P, 1991. \u0116tude d'un nouveau vaccin combin\u00e9 contre la fi\u00e8vre jaune et la rougeole chez les enfants ag\u00e9s de 6 au 24 mois au Mali","volume":"84"},{"key":"R22","series-title":"Bull Soc Pathol Exot","first-page":"537","article-title":"Garrigue G, 1990. \u0116tude de la vaccination combin\u00e9e rougeole-fi\u00e8vre jaune chez l'enfant africain ag\u00e9 de 6 \u00e0 10 mois","volume":"83"},{"key":"R23","series-title":"BMJ","first-page":"1090","article-title":"Encephalitis after yellow fever vaccination","volume":"1","year":"1955"},{"key":"R24","series-title":"MMWR Morb Mortal Wkly Rep","first-page":"130","article-title":"Transmission of yellow fever vaccine virus through breast feeding\u2014Brazil 2009","volume":"59","year":"2010"},{"key":"R25","series-title":"CMAJ","first-page":"E243","article-title":"Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk","volume":"183","year":"2011"},{"key":"R26","series-title":"Wkly Epidemiol Rec","first-page":"285","volume":"85","year":"2010"},{"key":"R27","series-title":"Trop Med Int Health","first-page":"833","article-title":"Early exposure to yellow fever vaccine during pregnancy","volume":"12","year":"2007"},{"key":"R28","series-title":"Trans R Soc Trop Med Hyg","first-page":"337","article-title":"Yellow fever vaccination and pregnancy: a four-year prospective study","volume":"87","year":"1993"},{"key":"R29","series-title":"Abs Intersci Conf Antimicrob Agents Chemother","first-page":"275","article-title":"Yellow fever vaccination during pregnancy","volume":"41","year":"2001"},{"key":"R30","series-title":"Vaccine","first-page":"1421","article-title":"The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil","volume":"24","year":"2006"},{"key":"R31","series-title":"J Travel Med","first-page":"77","article-title":"Impact of vaccines given during pregnancy on the offspring of women consulting a travel clinic: a longitudinal study","volume":"15","year":"2008"},{"key":"R32","series-title":"Trop Med Int Health","first-page":"29","article-title":"Yellow fever vaccination during pregnancy and spontaneous abortion: a case-control study","volume":"3","year":"1998"},{"key":"R33","series-title":"Vaccine","first-page":"283","article-title":"Exposure to yellow fever vaccine in early pregnancy","volume":"17","year":"1999"},{"key":"R34","series-title":"J Infect Dis","first-page":"1520","article-title":"Congenital yellow fever virus infection after immunization in pregnancy","volume":"168","year":"1993"},{"key":"R35","series-title":"Clin Infect Dis","first-page":"659","article-title":"Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients","volume":"48","year":"2009"},{"key":"R36","series-title":"J Travel Med","first-page":"145","article-title":"Good tolerance and efficacy of yellow fever vaccine among carriers of human immunodeficiency virus","volume":"2","year":"1995"},{"key":"R37","series-title":"Antibody response and safety of yellow fever vaccination in HIV infected patients. Proceedings of the 48th Annual International Conference on Antimicrobial Agents and Chemotherapy, October 25\u201328","first-page":"2008","year":"2008"},{"key":"R38","series-title":"Clin Infect Dis","first-page":"E7","article-title":"Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases","volume":"31","year":"2000"},{"key":"R39","series-title":"AIDS","first-page":"825","article-title":"Yellow fever vaccine is safe and effective in HIV-infected patients","volume":"18","year":"2004"},{"key":"R40","series-title":"Bull Epidemiologique Hebdomadaire","first-page":"238","article-title":"Immunog\u00e9nicit\u00e9 et tol\u00e9rance du vaccin amaril chez le voyageur vivant avec le VIH, France, 2005","volume":"25\/26","year":"2007"},{"key":"R41","series-title":"Curr HIV Res","first-page":"461","article-title":"Immunogenicity and tolerability of yellow fever vaccination in 23 French HIV-infected patients","volume":"8","year":"2010"},{"key":"R42","series-title":"AIDS Patient Care STDS","first-page":"65","article-title":"Vaccination in Brazilian HIV-infected adults: a cross-sectional study","volume":"22","year":"2008"},{"key":"R43","series-title":"J Med Assoc Thai","first-page":"131","article-title":"Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection","volume":"85","year":"2002"},{"key":"R44","series-title":"HIV Ther","first-page":"17","article-title":"Yellow fever vaccination in HIV-infected patients","volume":"4","year":"2010"},{"key":"R45","series-title":"Rev Soc Bras Med Trop","first-page":"23","article-title":"Vacina\u00e7\u00e3o contra febre amarela em pacientes com diagn\u00f3sticos de doen\u00e7as reum\u00e1ticas, em uso de immunosuppressores","volume":"42","year":"2009"},{"key":"R46","series-title":"J Allergy Clin Immunol","first-page":"698","article-title":"Anaphylaxis from yellow fever vaccine","volume":"1999","year":"1999"}],"container-title":["The American Society of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/86\/2\/article-p359.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/86\/2\/article-p359.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/86\/2\/article-p359.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T18:07:55Z","timestamp":1723054075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/86\/2\/article-p359.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,1]]},"references-count":46,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.2012.11-0525","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,1]]}}}